comparemela.com

Tycel Phillips News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Phillips on the Safety and Efficacy of Glofitamab in Relapsed/Refractory MCL

Tycel Phillips, MD, MPH, discusses updated efficacy and safety data with glofitamab for the treatment of relapsed/refractory mantle cell lymphoma.

City of Hope to Unveil New Cancer Treatments at 2024 ASCO Meeting

City of Hope to Unveil New Cancer Treatments at 2024 ASCO Meeting
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Dr Phillips on the Rationale for the GLOBRYTE Trial in Relapsed/Refractory MCL

Tycel Phillips, MD, discusses the rationale for launching the phase 3 GLOBRYTE trial evaluating glofitamab monotherapy in patients with relapsed/refractory mantle cell lymphoma, highlighting ongoing enrollment efforts.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.